Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US3795772082
Ticker GMED
Company GLOBUS MEDICAL
Currency $
Price
Aware Investor Index (AII) 0.0070
Recommendation STRONG SELL
P/E 67.54
ROE 7.67 %
Capitalization 5,013,772,140 $
Dividend Yield 0.00 %
P/S 7.88
AII Position 625
P/E Position 658
ROE Position 495
Capitalization Position 554
Dividend Yield Position 595
Sales 635,977,000 $
10-Year Average Earnings 74,237,100 $
Shares Outstanding 97,887,000
Equity 967,778,000 $
Dividend per Share 0 $
Industry Medical Equipment
Country United States
GLOBUS MEDICAL Investor Relations Web Site http://www.globusmedical.com/investors/sec-filings/







Sales:

YEAR MONTH AMOUNT
2017 12 635,977,000.00 $
2016 12 563,994,000.00 $
2015 12 544,753,000.00 $
2014 12 474,371,000.00 $
2013 12 434,459,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 107,348,000.00 $
2016 12 104,341,000.00 $
2015 12 112,784,000.00 $
2014 12 92,485,000.00 $
2013 12 68,612,000.00 $
2012 12 73,831,000.00 $
2011 12 60,784,000.00 $
2010 12 54,458,000.00 $
2009 12 48,733,000.00 $
2008 12 18,995,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 967,778,000.00 $
2016 12 832,078,000.00 $
2015 12 715,324,000.00 $
2014 12 585,454,000.00 $
2013 12 472,360,000.00 $
2012 12 386,502,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 97,887,000
2016 12 96,432,000
2015 12 96,073,000
2014 12 95,457,000
2013 12 94,192,000
2012 12 92,208,000

 












Bloomberg News for GLOBUS MEDICAL:



Google News for GLOBUS MEDICAL:

Seeking Alpha - 5 days ago
Globus Medical (GMED) Q3 2018 Results - Earnings Call Transcript
Globus Medical, Inc. (NYSE:GMED) Q3 2018 Earnings Call November 8, 2018 4:30 PM ET. Executives. Brian Kearns - Globus Medical, Inc.
GlobeNewswire (press release)
FDA warns Globus Medical over deficiencies at San Antonio site
Globus Medical (NYSE:GMED) discloses that it has received a Warning Letter from the FDA subsequent to an on-site inspection of subsidiary ...
Zacks.com
Is Globus Medical Inc's (NYSE:GMED) 13% ROE Strong Compared ...
By way of learning-by-doing, we'll look at ROE to gain a better understanding Globus Medical Inc (NYSE:GMED). Globus Medical has a ROE of ...
Motley Fool
Globus Medical beats by $0.07, beats on revenue
Globus Medical (NYSE:GMED): Q3 Non-GAAP EPS of $0.39 beats by $0.07; GAAP EPS of $0.35 beats by $0.03. Revenue of $169.2M (+11.5% ...
Seeking Alpha - 1 day ago
Globus Medical (GMED) likely to attain $60.33 in 52-week period
Globus Medical (GMED) stock managed performance -8.39% over the last week and switched with performance of -1.42% throughout past one month period.
Fairfield Current
Oppenheimer Reiterates $61.00 Price Target for Globus Medical ...
Oppenheimer set a $61.00 price target on Globus Medical (NYSE:GMED) in a research note issued to investors on Friday. The firm currently ...
Stock Digest (press release)
Piper Jaffray Companies Increases Globus Medical (GMED) Price ...
Globus Medical (NYSE:GMED) had its target price lifted by Piper Jaffray Companies to $62.00 in a report issued on Friday, The Fly reports.
Marea Informative (blog)
Globus Medical (GMED) Reports Next Week: Wall Street Expects ...
For the last reported quarter, it was expected that Globus Medical would post earnings of $0.35 per share when it actually produced earnings of ...
Simply Wall St - 1 day ago
IBD 50 Stock Plunges As Revenue Growth Hits Brakes In Third Quarter
Globus Medical (GMED) stock toppled Friday after the IBD 50 medical technology outlet beat third-quarter expectations but said revenue ...
Seeking Alpha - 5 days ago
This may help tick the clock: Globus Medical, Inc. (GMED), Weight ...
Globus Medical, Inc. (NYSE: GMED)'s stock value took a rollercoaster ride since the start of the recent year, with the year-to-date change of ...


Back